Overview

The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy

Status:
Terminated
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The investigators propose to study the effects of cannabidiol (CBD) on cardiac electrical function and the autonomic nervous system in children with Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS), when the CBD is administered as an artisanal oil obtained through state dispensaries or other sources. The intent is to begin to assess potential risks and benefits of this therapy in a vulnerable patient population by characterizing the effects of CBD on EKG findings, heart rate variability and the occurrence of seizures.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Gillette Children's Specialty Healthcare
Treatments:
Cannabidiol